Norifumi Shigemoto

Associate Professor

Hiroshima University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Norifumi Shigemoto is an Associate Professor at Hiroshima University, Japan. His research focuses on antiviral therapies, antimicrobial susceptibility, and pharmacokinetics related to surgical infections and COVID-19. He has contributed to recent publications addressing issues like combination therapies for COVID-19, antimicrobial patterns in surgical site infections, and pharmacokinetics of antibiotics in various bodily fluids. His work aims to enhance clinical outcomes and understanding of infectious diseases.

Articles (7)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Collaborators (2)

Norio Yamamoto

准教授 / Associate Professor

Kyoto University

JAPAN

View details

Hiroshi Yamazaki

Kyoto University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Norifumi Shigemoto

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Antiviral combination therapy in severely immunocompromised patients with persistent or recurrent COVID-19

Fourth nationwide surveillance of the antimicrobial susceptibility patterns of pathogens isolated from surgical site infections in Japan.

Non-tuberculous mycobacterial shoulder arthritis with acute exacerbation soon after initiation of immune checkpoint inhibitor: A case report

Blood culture bottles for culturing cerebrospinal fluid in cases of bacterial meningitis caused by Enterococcus faecalis: A case report

A multicenter study to investigate the positive rate of SARS-CoV-2 in middle ear and mastoid specimens from otologic surgery patients

Pharmacokinetics of cefmetazole in plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients scheduled for lower gastrointestinal surgery: Dosing considerations based on site-specific pharmacodynamic target attainment

Pharmacokinetics of flomoxef in plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients undergoing lower gastrointestinal surgery: Dosing considerations based on site-specific pharmacodynamic target attainment

Collaborators (2)

Norio Yamamoto

Hiroshi Yamazaki

Make your next move.